|
Name |
(4S,5R)-4-hydroxy-5-(hydroxymethyl)dihydrofuran-2(3H)-one
|
Molecular Formula | C5H8O4 | |
IUPAC Name* |
(4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-one
|
|
SMILES |
C1[C@@H]([C@H](OC1=O)CO)O
|
|
InChI |
InChI=1S/C5H8O4/c6-2-4-3(7)1-5(8)9-4/h3-4,6-7H,1-2H2/t3-,4+/m0/s1
|
|
InChIKey |
YIXDEYPPAGPYDP-IUYQGCFVSA-N
|
|
Synonyms |
34371-14-7; (4S,5R)-4-hydroxy-5-(hydroxymethyl)dihydrofuran-2(3H)-one; 2-Deoxyribonolactone; (4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-one; 2-Deoxy-D-ribonic acid-1,4-lactone; 2-deoxy-D-ribono-1,4-lactone; 2-Deoxy-ribono-1,4-lactone; Deoxyribonolactone; 2-Deoxy-D-ribonic-1,4-lactone; 2,4,5-Trihydroxypentanoic acid gamma-lactone; CHEBI:17281; 73209-20-8; 2-deoxy-D-erythro-pentonic acid gamma-lactone; rel-(4S,5R)-4-Hydroxy-5-(hydroxymethyl)dihydrofuran-2(3H)-one; 2'-Deoxyribolactone; MFCD15144952; 2-deoxyribono-1,4-lactone; CHEMBL98888; SCHEMBL3394583; DTXSID501308989; AMY34444; ZINC4095906; AKOS022184490; DS-18636; CS-0053170; C02674; P19126; 2-Deoxy-D-ribono-1,4-lactone, >=95% (GC); EN300-1699866; 371D147; D-erythro-Pentonic acid, 2-deoxy-, gamma-lactone; W-202407; Q27102301; (4S,5R)-4-Hydroxy-5-(hydroxymethyl)dihydro-2(3H)-furanone
|
|
CAS | 34371-14-7 | |
PubChem CID | 161815 | |
ChEMBL ID | CHEMBL98888 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 132.11 | ALogp: | -0.9 |
HBD: | 2 | HBA: | 4 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 66.8 | Aromatic Rings: | 1 |
Heavy Atoms: | 9 | QED Weighted: | 0.458 |
Caco-2 Permeability: | -5.132 | MDCK Permeability: | 0.00077590 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.033 |
Human Intestinal Absorption (HIA): | 0.016 | 20% Bioavailability (F20%): | 0.005 |
30% Bioavailability (F30%): | 0.709 |
Blood-Brain-Barrier Penetration (BBB): | 0.403 | Plasma Protein Binding (PPB): | 12.63% |
Volume Distribution (VD): | 0.576 | Fu: | 81.16% |
CYP1A2-inhibitor: | 0.02 | CYP1A2-substrate: | 0.063 |
CYP2C19-inhibitor: | 0.014 | CYP2C19-substrate: | 0.138 |
CYP2C9-inhibitor: | 0.002 | CYP2C9-substrate: | 0.102 |
CYP2D6-inhibitor: | 0.004 | CYP2D6-substrate: | 0.143 |
CYP3A4-inhibitor: | 0.009 | CYP3A4-substrate: | 0.09 |
Clearance (CL): | 4.803 | Half-life (T1/2): | 0.899 |
hERG Blockers: | 0.032 | Human Hepatotoxicity (H-HT): | 0.08 |
Drug-inuced Liver Injury (DILI): | 0.249 | AMES Toxicity: | 0.1 |
Rat Oral Acute Toxicity: | 0.013 | Maximum Recommended Daily Dose: | 0.014 |
Skin Sensitization: | 0.178 | Carcinogencity: | 0.343 |
Eye Corrosion: | 0.184 | Eye Irritation: | 0.956 |
Respiratory Toxicity: | 0.03 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001221 | 0.514 | D0Z4EI | 0.325 | ||||
ENC004082 | 0.417 | D0X5XU | 0.308 | ||||
ENC004083 | 0.333 | D0CL9S | 0.296 | ||||
ENC002314 | 0.310 | D0TS1Z | 0.296 | ||||
ENC000120 | 0.296 | D09PZO | 0.296 | ||||
ENC005200 | 0.286 | D0R2KF | 0.271 | ||||
ENC002838 | 0.286 | D0X7JN | 0.265 | ||||
ENC005694 | 0.286 | D05RHI | 0.262 | ||||
ENC004741 | 0.282 | D0H3KI | 0.250 | ||||
ENC000910 | 0.278 | D0Y7DP | 0.250 |